Integer (NYSE:ITGR) PT Raised to $150.00

Integer (NYSE:ITGR) had its price objective lifted by investment analysts at Truist Financial from $145.00 to $150.00 in a report issued on Monday, Benzinga reports. The firm currently has a “buy” rating on the medical equipment provider’s stock. Truist Financial’s price target would indicate a potential upside of 14.10% from the company’s previous close.

Several other research analysts also recently issued reports on ITGR. Bank of America upped their price objective on Integer from $135.00 to $145.00 and gave the stock a “buy” rating in a report on Tuesday, October 1st. Oppenheimer began coverage on Integer in a report on Tuesday, July 16th. They issued an “outperform” rating and a $135.00 price target on the stock. Citigroup boosted their price objective on Integer from $124.00 to $130.00 and gave the stock a “neutral” rating in a report on Tuesday, October 1st. Finally, Benchmark reaffirmed a “buy” rating and issued a $130.00 target price on shares of Integer in a research note on Wednesday, October 2nd. One analyst has rated the stock with a hold rating and six have given a buy rating to the stock. According to MarketBeat, Integer presently has an average rating of “Moderate Buy” and a consensus price target of $138.71.

Integer Stock Performance

Shares of NYSE:ITGR opened at $131.46 on Monday. The business has a fifty day moving average of $125.84 and a 200-day moving average of $120.34. The company has a debt-to-equity ratio of 0.73, a quick ratio of 1.96 and a current ratio of 3.29. Integer has a twelve month low of $69.40 and a twelve month high of $133.52. The firm has a market cap of $4.40 billion, a PE ratio of 45.49, a price-to-earnings-growth ratio of 1.86 and a beta of 1.08.

Integer (NYSE:ITGR) last posted its quarterly earnings data on Thursday, July 25th. The medical equipment provider reported $1.30 earnings per share for the quarter, beating the consensus estimate of $1.24 by $0.06. Integer had a net margin of 6.31% and a return on equity of 11.48%. The firm had revenue of $436.20 million during the quarter, compared to analysts’ expectations of $437.00 million. During the same quarter last year, the company posted $1.14 EPS. The company’s quarterly revenue was up 9.0% compared to the same quarter last year. On average, equities research analysts predict that Integer will post 5.3 EPS for the current fiscal year.

Insiders Place Their Bets

In related news, Director Jean M. Hobby sold 11,960 shares of the business’s stock in a transaction that occurred on Wednesday, July 31st. The shares were sold at an average price of $119.66, for a total transaction of $1,431,133.60. Following the completion of the transaction, the director now owns 2,280 shares in the company, valued at approximately $272,824.80. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Company insiders own 2.00% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in ITGR. Contravisory Investment Management Inc. grew its position in shares of Integer by 55.9% in the 3rd quarter. Contravisory Investment Management Inc. now owns 223 shares of the medical equipment provider’s stock valued at $29,000 after purchasing an additional 80 shares during the period. Quest Partners LLC increased its position in shares of Integer by 3,688.9% during the second quarter. Quest Partners LLC now owns 341 shares of the medical equipment provider’s stock worth $39,000 after acquiring an additional 332 shares in the last quarter. GAMMA Investing LLC raised its holdings in shares of Integer by 60.9% during the second quarter. GAMMA Investing LLC now owns 375 shares of the medical equipment provider’s stock worth $43,000 after acquiring an additional 142 shares during the period. Headlands Technologies LLC bought a new stake in Integer in the 1st quarter valued at $106,000. Finally, Innealta Capital LLC acquired a new position in Integer in the 2nd quarter worth $110,000. 99.29% of the stock is owned by institutional investors and hedge funds.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.